Mesenteric venous thrombosis
Mesenteric Venous Thrombosis (MVT) is a medical condition characterized by the formation of a thrombus (blood clot) within the mesenteric veins, which are responsible for draining blood away from the intestine. This condition can lead to decreased blood flow to the intestines, potentially resulting in intestinal ischemia, a serious condition that can cause damage to the intestinal tissues due to lack of oxygen.
Causes[edit | edit source]
Mesenteric venous thrombosis can be caused by a variety of factors, including hypercoagulability (an increased tendency to form blood clots), inflammation of the veins (thrombophlebitis), cancer, abdominal surgery, and certain genetic conditions. Other risk factors may include cirrhosis, pancreatitis, and inflammatory bowel disease.
Symptoms[edit | edit source]
The symptoms of MVT can vary but often include abdominal pain, nausea, vomiting, and diarrhea. The abdominal pain is typically severe and may be accompanied by bloating or a feeling of fullness. In advanced cases, blood may be present in the stool, indicating intestinal damage.
Diagnosis[edit | edit source]
Diagnosis of mesenteric venous thrombosis typically involves a combination of medical history, physical examination, and imaging studies. Computed tomography (CT) scans are commonly used to visualize the blood clot and assess the extent of intestinal damage. Other diagnostic tools may include magnetic resonance imaging (MRI) and ultrasound.
Treatment[edit | edit source]
Treatment for MVT focuses on dissolving the blood clot and restoring blood flow to the intestines. This may involve the use of anticoagulants (blood thinners) to prevent further clotting. In severe cases, thrombolytic therapy (medication to dissolve clots) or surgery may be necessary to remove the clot and repair any intestinal damage. Additionally, treatment of underlying conditions contributing to the development of MVT is crucial.
Prognosis[edit | edit source]
The prognosis for individuals with mesenteric venous thrombosis varies depending on the extent of the thrombosis and the presence of underlying conditions. Early diagnosis and treatment are essential for improving outcomes and preventing complications such as intestinal ischemia and sepsis.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD